A routine blood test that costs pennies and requires nothing more than a fasting sample of triglycerides and glucose may reveal far more about the future of the human heart than clinicians have long assumed. In one of the largest prospective investigations of its kind, researchers analyzing more than 31,000 middle-aged adults from the UK Biobank have found that elevated scores on the triglyceride-glucose index, a widely used surrogate marker of insulin resistance, are linked to a substantially increased risk of developing ischemic heart disease. More striking still, the study shows that this metabolic risk is partly channeled through measurable, silent structural changes in the heart itself, detectable on cardiac magnetic resonance imaging years before any symptom of disease appears.
The triglyceride-glucose index, usually abbreviated TyG, is calculated from the logarithm of the product of fasting triglyceride and fasting glucose concentrations. It has become a popular low-cost proxy for insulin resistance, the metabolic state in which tissues respond poorly to the hormone insulin and in which circulating fatty acids and sugars remain chronically elevated. Because insulin resistance sits upstream of type 2 diabetes, fatty liver disease, and atherosclerosis, the TyG index and a family of derivatives that combine it with measures of body size have been studied extensively as predictors of cardiovascular events. What has remained murky is the mechanism: does a high TyG score simply flag people destined for blocked coronary arteries, or does the metabolic environment itself begin to remodel the heart in ways that can be observed and quantified?
To answer that question, a team led by investigators at the China Three Gorges University affiliated Yichang Central People’s Hospital, working with collaborators at Ruhr University Bochum, the University of Glasgow, the University of Milan, and other European centers, turned to the UK Biobank, a vast biomedical database containing detailed imaging and health records for hundreds of thousands of participants. From this resource they identified 31,828 individuals who were free of ischemic heart disease at baseline and who had undergone cardiac magnetic resonance imaging, the gold-standard technique for measuring the volumes and pumping function of every cardiac chamber. For each participant the researchers computed the TyG index along with three obesity-composite derivatives: TyG-BMI, which incorporates body mass index; TyG-WC, which incorporates waist circumference; and TyG-WHtR, which incorporates waist-to-height ratio.
During the follow-up period, 1,768 participants developed incident ischemic heart disease, the umbrella term for conditions in which narrowed or blocked coronary arteries starve the heart muscle of oxygen, including angina and myocardial infarction. Using multivariable Cox proportional hazards models that adjusted for a broad range of demographic, lifestyle, and clinical confounders, the team found that every one of the TyG-related indices was positively and independently associated with the risk of a future cardiac event, with all associations reaching a statistical significance level below 0.001. Restricted cubic spline analyses indicated that the relationships were essentially continuous, meaning that risk climbed steadily with rising index values rather than appearing only above some threshold.
The ranking of the four indices carried its own message. TyG-WHtR, the version that folds in waist-to-height ratio, showed the strongest association with incident disease, with a hazard ratio of 1.221. The plain TyG index followed closely at 1.210, then TyG-WC at 1.200, and finally TyG-BMI at 1.163. The authors suggest that waist-to-height ratio, which captures central or visceral adiposity more faithfully than overall body mass, may make TyG-WHtR the preferred metabolic risk surrogate among the indices evaluated. Central fat depots are metabolically active, releasing free fatty acids and inflammatory signaling molecules directly into the portal circulation, and their combination with a glucose-lipid marker appears to sharpen the predictive signal considerably.
The truly novel step, however, came from the imaging. Because every participant had high-resolution cardiac magnetic resonance data, the researchers could ask whether the structural and functional parameters of the heart, measured at baseline, statistically mediated the link between metabolic score and later disease. Counterfactual mediation analysis, a technique that estimates how much of an observed association flows through an intermediate variable, revealed that subclinical remodeling of the heart accounted for a meaningful fraction of the effect. Left ventricular end-diastolic volume mediated 7.57 percent of the association, left ventricular end-systolic volume mediated 7.60 percent, and left ventricular ejection fraction, a measure of pumping efficiency, mediated 3.49 percent.
Even more impressive were the contributions from the chambers that are often overlooked in routine cardiology. The maximum volume of the left atrium, the receiving chamber that cushions the left ventricle with stored blood, mediated 21.09 percent of the TyG-disease association, the highest proportion of any parameter studied. On the right side of the heart, right ventricular end-diastolic volume mediated 18.67 percent and maximum right atrial volume mediated 14.83 percent. Taken together, these figures paint a picture of a heart that responds to early metabolic injury as a whole organ, with all four chambers undergoing subtle enlargement and functional drift long before a cardiologist would detect anything wrong with a stethoscope or an electrocardiogram.
Why would insulin resistance deform the heart in this way? The study’s authors and the broader literature point to several converging mechanisms. Chronically elevated free fatty acids force the myocardium to shift its fuel preference toward fat oxidation, a less oxygen-efficient metabolic route that promotes the accumulation of lipid intermediates within cardiac cells and can impair contractile proteins. Hyperinsulinemia activates growth signaling pathways in heart muscle, encouraging hypertrophy and fibrosis. Systemic inflammation and oxidative stress, both hallmarks of the insulin-resistant state, damage the microvasculature that feeds the heart wall and stiffen the extracellular matrix between cells. Epicardial adipose tissue, the fat layer wrapped around the heart itself, expands in metabolically unhealthy individuals and secretes pro-inflammatory cytokines directly into the myocardium. Each of these processes could plausibly enlarge atrial and ventricular chambers and gradually erode pumping reserve.
The clinical implications are considerable. Ischemic heart disease remains the leading cause of death worldwide, and a large share of first heart attacks occur in people who were never identified as high risk by conventional screening. A cheap, reproducible blood-derived index that can be combined with a tape-measure measurement of waist and height offers primary care physicians a practical early warning tool. The mediation findings add a mechanistic dimension: if part of the metabolic risk travels through structural cardiac remodeling, then imaging-based surveillance of high-TyG patients, particularly of atrial volumes, could in principle identify subclinical disease at a stage when aggressive lifestyle intervention and metabolic therapy might still alter the trajectory. The left atrium’s prominent mediating role is especially intriguing, since atrial enlargement is also a well-established substrate for atrial fibrillation, suggesting that metabolic injury may simultaneously set the stage for both ischemic and rhythm-related cardiac disease.
The authors are careful to frame the work as observational. Mediation analysis in cohort data can quantify statistical pathways but cannot prove causation with the certainty of a randomized trial, and residual confounding, measurement error in a single baseline blood sample, and the particular demographics of the UK Biobank population all temper generalization. Cardiac magnetic resonance imaging is also expensive and unlikely to enter routine screening for every patient with an elevated TyG score. Nevertheless, the scale of the cohort, the rigor of the adjustment, and the consistency of the associations across all four chambers give the findings substantial weight. They suggest that the heart is exquisitely sensitive to its metabolic environment, and that the earliest fingerprints of that sensitivity can be read from a simple blood draw and a measuring tape years before disease declares itself. As metabolic syndrome continues to spread across aging populations, tools that translate everyday laboratory values into a structural forecast of cardiac health may become indispensable allies in the fight against the world’s most lethal disease.
Subject of Research: The association between triglyceride-glucose index markers of insulin resistance and ischemic heart disease risk mediated by subclinical cardiac remodeling
Article Title: A structural cardiac pathway mediates the risk of ischemic heart disease from TyG-related indices: A prospective cohort study
Article References: Fan, Z., Liu, X., Shi, T., Yang, C., Huang, Y., Sieme, M., Tangos, M., Li, B., Sasko, B., Gao, W., Huang, J., Wintrich, J., Khan, M., Aweimer, A., Mügge, A., Maffia, P., Pellicori, P., Akin, I., van Heerebeek, L., … Yang, J. (2026). A structural cardiac pathway mediates the risk of ischemic heart disease from TyG-related indices: A prospective cohort study. BMC Medicine. https://doi.org/10.1186/s12916-026-05250-8
Image Credits: AI Generated
DOI: 10.1186/s12916-026-05250-8
Keywords: insulin resistance, triglyceride-glucose index, ischemic heart disease, cardiac remodeling, cardiac magnetic resonance, UK Biobank, left atrial volume, mediation analysis, cardiovascular risk, metabolic syndrome, ventricular function, prospective cohort study
News Source: Ophelia Keating. (October 6, 2026). Simple Blood Test Index Predicts Heart Attack Risk Through Silent Changes in All Four Heart Chambers. Scienmag.
